https://www.regmednet.com/first-engineered-t-cell-therapy-approved-for-solid-tumors/
FDA approval after the first cohort in the Phase 2 trial.
why is this important?
- T cell therapy is a slight variant to the car T cell therapies being developed by CHM
- therapy was successful against solid tumours
- first ever fda approved t call therapy for solid tumours
- Forums
- ASX - By Stock
- CHM
- Chimeric: Media Thread
Chimeric: Media Thread, page-833
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.18M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.6¢ | $11.35K | 702.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 1886263 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 168006 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 1886263 | 0.016 |
12 | 2236452 | 0.015 |
3 | 708475 | 0.014 |
2 | 222223 | 0.013 |
2 | 83412 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 168006 | 2 |
0.018 | 508453 | 2 |
0.019 | 807601 | 5 |
0.020 | 1523093 | 7 |
0.021 | 282857 | 2 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online